Literature DB >> 25983906

Viruses may trigger allopurinol hypersensitivity syndrome.

Masami Koike1, Yoshihiko Kanno1, Koji Tomori1, Hirokazu Okada1, Hiromichi Suzuki1.   

Abstract

Entities:  

Year:  2008        PMID: 25983906      PMCID: PMC4421215          DOI: 10.1093/ndtplus/sfn042

Source DB:  PubMed          Journal:  NDT Plus        ISSN: 1753-0784


× No keyword cloud information.
Sir, A relationship between allopurinol hypersensitivity syndrome (AHS) and viral infections, especially with human herpes virus (HHV)-6, has been suspected since the first report of AHS in 1970 [1]. Although participation of other opportunistic viral infections has also been reported, the mechanisms by which any of these contribute to AHS are still unknown. We report a case of a 39-year-old woman receiving peritoneal dialysis due to lupus nephritis who developed severe AHS, which may have resulted from influenza virus infection. She experienced a systemic skin rash with high fever just after administration of allopurinol. Both hypereosinophilia and high titre influenza virus type A-specific antibody were present before admission and at hospital day 6. Because antibody titres for HHV-6 IgG, Epstein-Barr virus, measles and rubella were positive but within the normal range, we suspected that the AHS may have been induced by influenza virus infection. Her symptoms diminished following withdrawal of allopurinol and administration of predonisolone. Current hypotheses for mechanisms of the AHS onset include two pathways Fig. 1. First, storage of allopurinol and its metabolite, oxypurinol, may directly inflict cell damage, especially in patients with renal dysfunction. A second possible pathway suggests that a type III allergic reaction caused by allopurinol may induce the re-activation of HHV-6, or activation of other opportunistic viruses, such as cytomegalovirus [2] and Epstein-Barr virus [3], through the activation of T-lymphocytes. Recently, CD46 was identified as a receptor for HHV-6, and it was therefore suggested that this reactivated virus damages cells, including epidermal cells and lymphocytes, via CD46 binding [4]. In the present case, the influenza virus titre was elevated in parallel with the clinical symptoms of AHS, and it is possible that this virus exacerbated the cascade reaction in the same way as do other viruses. We suggest that such community-acquired bacterial and viral infections may also accelerate these cascade reactions and that genetic factors may interact with these events.
Fig. 1

Possible mechanism for the onset of allopurinol hypersensitivity syndrome. In addition to established pathways (direct cellular injury and inactivation of viruses), community infection may accelerate the cascade.

Possible mechanism for the onset of allopurinol hypersensitivity syndrome. In addition to established pathways (direct cellular injury and inactivation of viruses), community infection may accelerate the cascade. Conflict of interest statement. None declared.
  4 in total

1.  CD46 is a cellular receptor for human herpesvirus 6.

Authors:  F Santoro; P E Kennedy; G Locatelli; M S Malnati; E A Berger; P Lusso
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

2.  Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia.

Authors:  M Arakawa; Y Kakuto; K Ichikawa; J Chiba; N Tabata; Y Sasaki
Journal:  Intern Med       Date:  2001-04       Impact factor: 1.271

3.  Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.

Authors:  V Descamps; E Mahe; N Houhou; L Abramowitz; F Rozenberg; S Ranger-Rogez; B Crickx
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

4.  Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.

Authors:  Y Suzuki; R Inagi; T Aono; K Yamanishi; T Shiohara
Journal:  Arch Dermatol       Date:  1998-09
  4 in total
  2 in total

1.  A pilot in distress.

Authors:  Sophie Bennett; Nicos Mitsides; Ajay Dhaygude; Alexander Woywodt
Journal:  NDT Plus       Date:  2009-11-03

Review 2.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.